B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein

REACTOME PATHWAY
Reactome: R-HSA-4461935 genes12 compounds

The Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein pathway (Reactome ID: R-HSA-446193) involves 5 genes and is affected by 12 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

CTSAMPINEU2NEU3SLC17A5

Compounds Affecting Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein

#CompoundTargets HitStudies
1Zanamivir297
2caffeic acid300
3egcg300
4Rutin300
5Metergoline144
6Methyldopa297
7Oxytetracycline300
8streptonigrin299
9Tolazamide169
10Oseltamivir297
11Methotrexate289
12Bortezomib300

About the Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein Pathway

The Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein pathway is catalogued in Reactome (ID: R-HSA-446193) and involves 5 genes. In the BiohacksAI corpus, 12 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include CTSA, MPI, NEU2, NEU3, SLC17A5.